4DMedical Ltd ( (AU:4DX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd’s stock is on the rise due to its expanded distribution agreement with Philips, which now includes the innovative CT:VQ™ technology in North America. This move targets a US$10 million market over the next two years and enhances the company’s position in the U.S. diagnostic market by eliminating the need for radiotracers, thus improving patient access. Despite the promising developments, analysts maintain a Hold rating on the stock, influenced by current market conditions and recent deals.
More about 4DMedical Ltd
YTD Price Performance: 263.54%
Average Trading Volume: 7,792,000
Technical Sentiment Signal: Buy
Current Market Cap: A$900.5M
For further insights into 4DX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.

